Keyphrases
Activin
100%
Type I Receptor
100%
Bone Morphogenetic Protein Receptor
100%
Smad Signaling Pathway
100%
ACVR2A
100%
Bone Morphogenetic Protein
63%
Activin Type II Receptor
54%
Smad2
36%
Smad1
36%
ALK4
36%
ACVR2
36%
Protein Type
27%
Activin Receptor-like Kinase 2 (ALK2)
27%
Complex Formation
18%
Smad
18%
Novel Mechanism
9%
Immobilization
9%
Overexpression
9%
Physiological Processes
9%
Plasma Membrane
9%
Lateral Diffusion
9%
Cellular Response
9%
Pathological Process
9%
Transforming Growth Factor-β
9%
U2OS Cells
9%
Fluorescence Recovery
9%
Form-stable
9%
Heteromeric Complexes
9%
ALK3
9%
Potential Competition
9%
BMP9
9%
Competing Types
9%
BMP9 Signaling
9%
Differential Complex
9%
Neuroscience
Bone Morphogenetic Protein Receptor
100%
Activin
100%
Bone Morphogenetic Protein
66%
Bone Morphogenetic Protein Receptor, Type 1
50%
Activin Receptor 2
50%
Eicosanoid Receptor
33%
Activin A
33%
Complex Formation
33%
Bone Morphogenetic Protein 9
33%
Epileptic Absence
16%
Cell Membrane
16%
Transforming Growth Factor
16%
Fluorescence Recovery after Photobleaching
16%
Activin Receptor 1
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Morphogenetic Protein Receptor
100%
Activin
100%
Bone Morphogenetic Protein
66%
Activin Receptor 2
50%
Bone Morphogenetic Protein Receptor 1
50%
Receptor
33%
Activin A
33%
Bone Morphogenetic Protein 9
33%
Disease
16%
Epileptic Absence
16%
Transforming Growth Factor
16%
Activin Receptor 1
16%
Biochemistry, Genetics and Molecular Biology
Activin
100%
Bone Morphogenetic Protein
100%
ACVR2A
100%
Eicosanoid Receptor
33%
Bone Morphogenetic Protein Receptor, Type 1
33%
Activin Type 2 Receptors
33%
Complex Formation
22%
Facilitated Diffusion
11%
Cell Membrane
11%
Transforming Growth Factor
11%
Fluorescence Recovery after Photobleaching
11%